IGM Biosciences (IGMS) Presents At RBC Capital Markets Global Healthcare Conference

Pioneering the Development of Engineered IgM Antibodies IGM Corporate Presentation RBC Capital Markets Global Healthcare Conference May 19, 2021 Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect the current views of IGM Biosciences, Inc. (the "Company," "we" or "our") with respect to the Company's future financial condition, results of operations, business strategy, expectations, mileston ...